Novartis Investigative Site

Trento, TN 38122

1 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Breast Cancer, Carcinoma, Hypernephroid, Metastatic Hormone-sensitive Prostate Cancer, Nephroid Carcinoma, Renal Cell

Studies at this site

• An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) — Recruiting now
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer — Completed